Stroke:可逆性脑血管收缩综合征,有何临床特点?

2021-09-07 Freeman MedSci原创

以整个美国人口推算,每年有>1000名RCVS患者住院,其中大多数是中年妇女

近年来,可逆性脑血管收缩综合征(RCVS)已被越来越多的人认识。来自美国、亚洲和欧洲的系列报道共描述了900名患者。RCVS可表现为许多症状和并发症,从没有脑部病变的孤立的严重头痛,到罕见的有多处中风的严重形式。该病在女性和中年人中最常见。

美国缺乏关于RCVS住院频率、病人和医院层面特征的当代数据。从以往的病例系列来看,短期疗效大多很好,但RCVS可导致严重残疾,在美国的两个系列中,死亡率达到2%至7%。

不良的结果与缺血性和出血性中风有关。在RCVS的并发症中存在着人群间的差异,这可能是由于个别病例系列中的患者数量有限,以及从不同环境(头痛诊所和住院病人)收集的患者的异质性。


为了解决这一知识空白,美国康涅狄格大学的 Smit D. Patel等人使用了美国最大的全国住院病人数据库来确定RCVS的频率、特征和与短期结果相关的因素。

他们分析了美国全国住院病人样本数据库(2016-2017),以描述RCVS的住院频率、人口统计学特征、住院病人死亡率和出院结果。

在2年的研究期间,全国范围内的住院样本医院共收治了2020名RCVS患者,占全国每10万次住院的0.02例。入院时的平均年龄为47.6岁,85%在65岁以下,75.5%为女性。

住院期间合并的神经系统诊断包括缺血性中风(17.1%)、脑内出血(11.0%)、蛛网膜下腔出血(32.7%)、癫痫症(6.7%)和可逆性脑水肿(13.6%)。

总体而言,70%的患者出院回家,29.7%的患者出院到康复机构或疗养院,0.3%的患者在出院前死亡。与出院到其他机构或死亡的不良结果独立相关的患者特征是高龄(几率比[OR],1.04[95% CI,1.03-1.04])、女性(OR,2.45[1.82-3.34])、脑内出血(OR,2。 91 [1.96-4.31]),缺血性中风(OR,5.72 [4.32-7.58]),癫痫病(OR,2.61 [1.70-4.00]),可逆性脑水肿(OR,6.26 [4.41-8.89]),心房颤动(OR,2.97 [1.83-4.81]),和慢性肾病(OR,3.43 [2.19-5.36])。

这个研究的重要意义在于发现了:以整个美国人口推算,每年有>1000名RCVS患者住院,其中大多数是中年妇女,约有300人出院后至少需要一些康复或疗养院护理。与RCVS相关的住院病人死亡率很少。


原文出处:
Patel SD, Topiwala K, Otite Oliver F, et al. Outcomes Among Patients With Reversible Cerebral Vasoconstriction Syndrome: A Nationwide United States Analysis. Stroke. Published online September 2, 2021. doi:10.1161/STROKEAHA.121.034424

评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1933896, encodeId=87a61933896ee, content=<a href='/topic/show?id=7c1c2288877' target=_blank style='color:#2F92EE;'>#临床特点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22888, encryptionId=7c1c2288877, topicName=临床特点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3679417, createdName=feather78, createdTime=Wed Apr 27 11:58:45 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950652, encodeId=43ae195065257, content=<a href='/topic/show?id=e3928966841' target=_blank style='color:#2F92EE;'>#血管收缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89668, encryptionId=e3928966841, topicName=血管收缩)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b30126, createdName=skhzy, createdTime=Tue Nov 16 02:58:45 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935819, encodeId=63cd1935819b3, content=<a href='/topic/show?id=aa93385331c' target=_blank style='color:#2F92EE;'>#可逆性脑血管收缩综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38533, encryptionId=aa93385331c, topicName=可逆性脑血管收缩综合征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85152500072, createdName=124987c6m36暂无昵称, createdTime=Sat Jan 01 05:58:45 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432138, encodeId=36471432138d6, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Sep 09 20:58:45 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580258, encodeId=cfb2158025849, content=<a href='/topic/show?id=76743853197' target=_blank style='color:#2F92EE;'>#可逆性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38531, encryptionId=76743853197, topicName=可逆性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=023016601943, createdName=小华子, createdTime=Thu Sep 09 20:58:45 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015900, encodeId=d1bc101590020, content=新的理论,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df324723890, createdName=452946589, createdTime=Wed Sep 08 23:32:39 CST 2021, time=2021-09-08, status=1, ipAttribution=)]
    2022-04-27 feather78
  2. [GetPortalCommentsPageByObjectIdResponse(id=1933896, encodeId=87a61933896ee, content=<a href='/topic/show?id=7c1c2288877' target=_blank style='color:#2F92EE;'>#临床特点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22888, encryptionId=7c1c2288877, topicName=临床特点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3679417, createdName=feather78, createdTime=Wed Apr 27 11:58:45 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950652, encodeId=43ae195065257, content=<a href='/topic/show?id=e3928966841' target=_blank style='color:#2F92EE;'>#血管收缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89668, encryptionId=e3928966841, topicName=血管收缩)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b30126, createdName=skhzy, createdTime=Tue Nov 16 02:58:45 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935819, encodeId=63cd1935819b3, content=<a href='/topic/show?id=aa93385331c' target=_blank style='color:#2F92EE;'>#可逆性脑血管收缩综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38533, encryptionId=aa93385331c, topicName=可逆性脑血管收缩综合征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85152500072, createdName=124987c6m36暂无昵称, createdTime=Sat Jan 01 05:58:45 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432138, encodeId=36471432138d6, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Sep 09 20:58:45 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580258, encodeId=cfb2158025849, content=<a href='/topic/show?id=76743853197' target=_blank style='color:#2F92EE;'>#可逆性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38531, encryptionId=76743853197, topicName=可逆性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=023016601943, createdName=小华子, createdTime=Thu Sep 09 20:58:45 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015900, encodeId=d1bc101590020, content=新的理论,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df324723890, createdName=452946589, createdTime=Wed Sep 08 23:32:39 CST 2021, time=2021-09-08, status=1, ipAttribution=)]
    2021-11-16 skhzy
  3. [GetPortalCommentsPageByObjectIdResponse(id=1933896, encodeId=87a61933896ee, content=<a href='/topic/show?id=7c1c2288877' target=_blank style='color:#2F92EE;'>#临床特点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22888, encryptionId=7c1c2288877, topicName=临床特点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3679417, createdName=feather78, createdTime=Wed Apr 27 11:58:45 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950652, encodeId=43ae195065257, content=<a href='/topic/show?id=e3928966841' target=_blank style='color:#2F92EE;'>#血管收缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89668, encryptionId=e3928966841, topicName=血管收缩)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b30126, createdName=skhzy, createdTime=Tue Nov 16 02:58:45 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935819, encodeId=63cd1935819b3, content=<a href='/topic/show?id=aa93385331c' target=_blank style='color:#2F92EE;'>#可逆性脑血管收缩综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38533, encryptionId=aa93385331c, topicName=可逆性脑血管收缩综合征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85152500072, createdName=124987c6m36暂无昵称, createdTime=Sat Jan 01 05:58:45 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432138, encodeId=36471432138d6, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Sep 09 20:58:45 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580258, encodeId=cfb2158025849, content=<a href='/topic/show?id=76743853197' target=_blank style='color:#2F92EE;'>#可逆性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38531, encryptionId=76743853197, topicName=可逆性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=023016601943, createdName=小华子, createdTime=Thu Sep 09 20:58:45 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015900, encodeId=d1bc101590020, content=新的理论,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df324723890, createdName=452946589, createdTime=Wed Sep 08 23:32:39 CST 2021, time=2021-09-08, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1933896, encodeId=87a61933896ee, content=<a href='/topic/show?id=7c1c2288877' target=_blank style='color:#2F92EE;'>#临床特点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22888, encryptionId=7c1c2288877, topicName=临床特点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3679417, createdName=feather78, createdTime=Wed Apr 27 11:58:45 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950652, encodeId=43ae195065257, content=<a href='/topic/show?id=e3928966841' target=_blank style='color:#2F92EE;'>#血管收缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89668, encryptionId=e3928966841, topicName=血管收缩)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b30126, createdName=skhzy, createdTime=Tue Nov 16 02:58:45 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935819, encodeId=63cd1935819b3, content=<a href='/topic/show?id=aa93385331c' target=_blank style='color:#2F92EE;'>#可逆性脑血管收缩综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38533, encryptionId=aa93385331c, topicName=可逆性脑血管收缩综合征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85152500072, createdName=124987c6m36暂无昵称, createdTime=Sat Jan 01 05:58:45 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432138, encodeId=36471432138d6, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Sep 09 20:58:45 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580258, encodeId=cfb2158025849, content=<a href='/topic/show?id=76743853197' target=_blank style='color:#2F92EE;'>#可逆性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38531, encryptionId=76743853197, topicName=可逆性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=023016601943, createdName=小华子, createdTime=Thu Sep 09 20:58:45 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015900, encodeId=d1bc101590020, content=新的理论,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df324723890, createdName=452946589, createdTime=Wed Sep 08 23:32:39 CST 2021, time=2021-09-08, status=1, ipAttribution=)]
    2021-09-09 zhouqu_8
  5. [GetPortalCommentsPageByObjectIdResponse(id=1933896, encodeId=87a61933896ee, content=<a href='/topic/show?id=7c1c2288877' target=_blank style='color:#2F92EE;'>#临床特点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22888, encryptionId=7c1c2288877, topicName=临床特点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3679417, createdName=feather78, createdTime=Wed Apr 27 11:58:45 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950652, encodeId=43ae195065257, content=<a href='/topic/show?id=e3928966841' target=_blank style='color:#2F92EE;'>#血管收缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89668, encryptionId=e3928966841, topicName=血管收缩)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b30126, createdName=skhzy, createdTime=Tue Nov 16 02:58:45 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935819, encodeId=63cd1935819b3, content=<a href='/topic/show?id=aa93385331c' target=_blank style='color:#2F92EE;'>#可逆性脑血管收缩综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38533, encryptionId=aa93385331c, topicName=可逆性脑血管收缩综合征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85152500072, createdName=124987c6m36暂无昵称, createdTime=Sat Jan 01 05:58:45 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432138, encodeId=36471432138d6, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Sep 09 20:58:45 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580258, encodeId=cfb2158025849, content=<a href='/topic/show?id=76743853197' target=_blank style='color:#2F92EE;'>#可逆性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38531, encryptionId=76743853197, topicName=可逆性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=023016601943, createdName=小华子, createdTime=Thu Sep 09 20:58:45 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015900, encodeId=d1bc101590020, content=新的理论,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df324723890, createdName=452946589, createdTime=Wed Sep 08 23:32:39 CST 2021, time=2021-09-08, status=1, ipAttribution=)]
    2021-09-09 小华子
  6. [GetPortalCommentsPageByObjectIdResponse(id=1933896, encodeId=87a61933896ee, content=<a href='/topic/show?id=7c1c2288877' target=_blank style='color:#2F92EE;'>#临床特点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22888, encryptionId=7c1c2288877, topicName=临床特点)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3679417, createdName=feather78, createdTime=Wed Apr 27 11:58:45 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1950652, encodeId=43ae195065257, content=<a href='/topic/show?id=e3928966841' target=_blank style='color:#2F92EE;'>#血管收缩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89668, encryptionId=e3928966841, topicName=血管收缩)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b30126, createdName=skhzy, createdTime=Tue Nov 16 02:58:45 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1935819, encodeId=63cd1935819b3, content=<a href='/topic/show?id=aa93385331c' target=_blank style='color:#2F92EE;'>#可逆性脑血管收缩综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38533, encryptionId=aa93385331c, topicName=可逆性脑血管收缩综合征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85152500072, createdName=124987c6m36暂无昵称, createdTime=Sat Jan 01 05:58:45 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1432138, encodeId=36471432138d6, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Sep 09 20:58:45 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1580258, encodeId=cfb2158025849, content=<a href='/topic/show?id=76743853197' target=_blank style='color:#2F92EE;'>#可逆性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38531, encryptionId=76743853197, topicName=可逆性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=023016601943, createdName=小华子, createdTime=Thu Sep 09 20:58:45 CST 2021, time=2021-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015900, encodeId=d1bc101590020, content=新的理论,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df324723890, createdName=452946589, createdTime=Wed Sep 08 23:32:39 CST 2021, time=2021-09-08, status=1, ipAttribution=)]
    2021-09-08 452946589

    新的理论,学习了

    0

相关资讯

Stroke:脑中风后,患者的长期生活功能如何变化?

在脑卒中后的慢性阶段,功能限制首先趋于平稳,然后增加,其演变因残疾的严重程度而异

JAMA子刊:卒中急救成绩卓然——不同卒中中心在卒中患者分流情况对比

实施综合卒中中心分流的院前转运政策与AIS患者EVT率的显著、快速和持续增加有关

JAMA Neurology:脑卒中后,使用氟西汀是否能有效缓解抑郁症状?

与安慰剂相比,每天使用20毫克氟西汀的常规治疗并没有减少中风后出现临床显著抑郁症状的人的比例,也没有影响开抗抑郁药或接受非药物治疗的人的比例。

Stroke:替格瑞洛-阿司匹林联用治疗卒中,利大于弊

在轻中度缺血性卒中或高危TIA患者中,使用ticagrelor-aspirin进行30天治疗的缺血益处超过了出血风险。

Stroke : 脑中风后,血压管理,存在种族差异

与有或无卒中的白人成年人相比,黑人控制血压的比例较低,

拓展阅读

European Radiology:脑卒中MRI运动伪影的影响及相关因素分析

本研究基于临床真实世界数据,系统评估运动伪影的临床流行特征,分析其影响因素,并量化其对AI工具及放射科人类诊断敏感性和特异性的具体影响,为未来优化影像质量管理及AI模型的训练和应用提供依据。

中风后运动恢复的"秘密通道":科学家首次发现大脑运动区与脊髓连接异常​

随着神经影像技术的进步,未来我们有望更精确地定位异常连接位点,开发出更个性化的康复方案,让更多中风患者重获运动自由。

NEJM:卒中取栓术前静脉注射替奈普酶的疗效与安全性研究

静脉替奈普酶接取栓治疗大血管闭塞卒中可提高90天功能独立率,但症状性颅内出血风险略增。再灌注时间缩短9分钟,超140分钟亚组仍获益,但开放标签设计及效应量低于预设限制结论强度。

从 “突然失语” 到 “偏瘫卧床”:真实病例 + 前沿研究,看懂脑卒中的致命威胁

近一年,医学界对脑卒中的研究持续突破,从超早期溶栓治疗到神经保护新策略,每一个进展都关乎万千患者的生命与生活质量。​

Eur J Prev Cardiol:心梗 / 卒中患者中约 15% 新诊糖尿病,筛查需求迫切

在因心肌梗塞或卒中入院的患者中,六分之一的人被新诊断为糖尿病。改善糖尿病筛查可以帮助人们在发生与糖尿病相关的心血管事件之前识别出来。

Stroke: 每天多吃一口膳食纤维,中风风险降三成

每天应该保证25-30克的膳食纤维摄入量,相当于约3份全谷物+2份水果+3份蔬菜。

脑卒中恢复期患者居家康复指南

暂未更新 · 2025-05-06